About Lathian Systems
Lathian Systems is a company based in Plymouth Meeting (United States) founded in 2000 was acquired by D & R Communications in February 2012. Lathian Systems has raised $14 million across 2 funding rounds from investors including Credit Suisse, HWVP and D & R Communications. Lathian Systems operates in a competitive market with competitors including ACTO, Digital Pharmacist, IMS Health, Axtria and Evariant, among others.
- Headquarter Plymouth Meeting, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14 M (USD)
in 2 rounds
-
Latest Funding Round
$9 M (USD), Series B
Feb 26, 2001
-
Investors
Credit Suisse
& 2 more
-
Employee Count
Not available
-
Acquired by
D & R Communications
(Feb 01, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lathian Systems
Lathian Systems has successfully raised a total of $14M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $9 million completed in February 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lathian Systems
Lathian Systems has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, HWVP and D & R Communications.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage US tech startups are invested in by HWVP.
|
Locked | Locked | Locked | |
|
Wealth management, asset management, and investment banking services are offered.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Lathian Systems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lathian Systems
Investment portfolio details for Lathian Systems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lathian Systems
Detailed financials for Lathian Systems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lathian Systems Comparisons
Peer comparison for Lathian Systems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lathian Systems
Lathian Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ACTO, Digital Pharmacist, IMS Health, Axtria and Evariant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI and SaaS-based educational platform for life sciences is provided.
|
|
| Locked | Locked | Locked |
Platform offering CRM software for pharmacies
|
|
| Locked | Locked | Locked |
SaaS and AI-based market intelligence is provided for healthcare companies.
|
|
| Locked | Locked | Locked |
Data analytics and AI solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provides platform for digital marketing solutions
|
|
| Locked | Locked | Locked |
Web-based software for long term care, senior living, and assisted living
|
Detailed competitors of Lathian Systems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lathian Systems
Complete news archive for Lathian Systems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lathian Systems
Lathian Systems was founded in 2000.
Lathian Systems is headquartered in Plymouth Meeting, United States. It is registered at Plymouth Meeting, Pennsylvania, United States.
Lathian Systems is a funded company, having raised a total of $14M across 2 funding rounds to date.
Lathian Systems, formerly known as MyDrugRep.com, is a provider of online solutions for relationship marketing for pharmaceutical and biotech companies. Investors in the company include New Leaf Venture Partners and Hummer Winblad Venture Partners (HWVP). In 2012, the company was acquired by DR Communications and rebranded as DR Lathian.
Lathian Systems's top competitors include Axtria, ACTO and Digital Pharmacist.
Lathian Systems has 3 investors. Key investors include Credit Suisse, HWVP, and D & R Communications.